KINNATE BIOPHARMA INC

CUSIP: 49705R105 Class: Common Stock

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 8,009,729 Value ($000) $21,306 Avg Close — Range —
Q4 2023
Shares 8,009,729 Value ($000) $18,983 Avg Close — Range —
Q3 2023
Shares 8,009,729 Value ($000) $11,214 Avg Close — Range —
Q2 2023
Shares 8,009,729 Value ($000) $24,269 Avg Close — Range —
Q1 2023
Shares 5,143,629 Value ($000) $32,148 Avg Close — Range —
Q4 2022
Shares 4,043,629 Value ($000) $24,666 Avg Close — Range —
Q3 2022
Shares 4,043,629 Value ($000) $48,321 Avg Close — Range —
Q2 2022
Shares 4,043,629 Value ($000) $50,990 Avg Close — Range —
Q1 2022
Shares 4,043,629 Value ($000) $45,531 Avg Close — Range —
Q4 2021
Shares 3,847,929 Value ($000) $68,185 Avg Close — Range —
Q3 2021
Shares 3,847,929 Value ($000) $88,579 Avg Close — Range —
Q2 2021
Shares 3,847,929 Value ($000) $89,580 Avg Close — Range —
Q1 2021
Shares 3,847,929 Value ($000) $119,901 Avg Close — Range —
Q4 2020
Shares 3,847,929 Value ($000) $153,071 Avg Close — Range —